Literature DB >> 15995221

The F1Fo-ATP synthase of Mycobacterium smegmatis is essential for growth.

Sieu L Tran1, Gregory M Cook.   

Abstract

The F(1)F(o)-ATP synthase plays an important role in a number of vital cellular processes in plants, animals, and microorganisms. In this study, we constructed a DeltaatpD mutant of Mycobacterium smegmatis and demonstrated that atpD encoding the beta subunit of the F(1)F(o)-ATP synthase is an essential gene in M. smegmatis during growth on nonfermentable and fermentable carbon sources.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15995221      PMCID： PMC1169501          DOI： 10.1128/JB.187.14.5023-5028.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  29 in total

1.  Rapid mycobacterial plasmid analysis by electroduction between Mycobacterium spp. and Escherichia coli.

Authors:  A Baulard; C Jourdan; A Mercenier; C Locht
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

2.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

Review 3.  The ATP synthase--a splendid molecular machine.

Authors:  P D Boyer
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

4.  Analysis of F1F0-ATPase from Helicobacter pylori.

Authors:  C C McGowan; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.

Authors:  L Miesel; T R Weisbrod; J A Marcinkeviciene; R Bittman; W R Jacobs
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

6.  Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs.

Authors:  Edward A Weinstein; Takahiro Yano; Lin-Sheng Li; David Avarbock; Andrew Avarbock; Douglas Helm; Andrew A McColm; Ken Duncan; John T Lonsdale; Harvey Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

7.  Growth of Mycobacterium tuberculosis in a defined medium is very restricted by acid pH and Mg(2+) levels.

Authors:  D L Piddington; A Kashkouli; N A Buchmeier
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Altered NADH/NAD+ ratio mediates coresistance to isoniazid and ethionamide in mycobacteria.

Authors:  Catherine Vilchèze; Torin R Weisbrod; Bing Chen; Laurent Kremer; Manzour H Hazbón; Feng Wang; David Alland; James C Sacchettini; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

9.  Mutants of Mycobacterium smegmatis unable to grow at acidic pH in the presence of the protonophore carbonyl cyanide m-chlorophenylhydrazone.

Authors:  Sieu L Tran; Min Rao; Cameron Simmers; Susanne Gebhard; Karen Olsson; Gregory M Cook
Journal:  Microbiology (Reading)       Date:  2005-03       Impact factor: 2.777

10.  New use of BCG for recombinant vaccines.

Authors:  C K Stover; V F de la Cruz; T R Fuerst; J E Burlein; L A Benson; L T Bennett; G P Bansal; J F Young; M H Lee; G F Hatfull
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962
View more
  37 in total

1.  Essential genes in Salmonella enteritidis as identified by TnAraOut mutagenesis.

Authors:  Jeong Nam Kim; Gun Woong Youm; Young Min Kwon
Journal:  Curr Microbiol       Date:  2008-08-14       Impact factor: 2.188

Review 2.  The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target.

Authors:  Hyungjin Eoh; Patrick J Brennan; Dean C Crick
Journal:  Tuberculosis (Edinb)       Date:  2008-09-14       Impact factor: 3.131

Review 3.  Bedaquiline - The first ATP synthase inhibitor against multi drug resistant tuberculosis.

Authors:  Mageshwaran Lakshmanan; Alphienes Stanley Xavier
Journal:  J Young Pharm       Date:  2013-12-30

4.  Turbine enzyme's structure in the crosshairs to target tuberculosis.

Authors:  Thomas M Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-19       Impact factor: 11.205

Review 5.  Oxidative Phosphorylation as a Target Space for Tuberculosis: Success, Caution, and Future Directions.

Authors:  Gregory M Cook; Kiel Hards; Elyse Dunn; Adam Heikal; Yoshio Nakatani; Chris Greening; Dean C Crick; Fabio L Fontes; Kevin Pethe; Erik Hasenoehrl; Michael Berney
Journal:  Microbiol Spectr       Date:  2017-06

6.  Antimicrobial mechanism of action of transferrins: selective inhibition of H+-ATPase.

Authors:  María T Andrés; José F Fierro
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

7.  Ionophoric effects of the antitubercular drug bedaquiline.

Authors:  Kiel Hards; Duncan G G McMillan; Lici A Schurig-Briccio; Robert B Gennis; Holger Lill; Dirk Bald; Gregory M Cook
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

8.  The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of D-alanine.

Authors:  Daniel L Milligan; Sieu L Tran; Ulrich Strych; Gregory M Cook; Kurt L Krause
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

9.  Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia.

Authors:  Michael Berney; Gregory M Cook
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

10.  The low-affinity phosphate transporter PitA is dispensable for in vitro growth of Mycobacterium smegmatis.

Authors:  Susanne Gebhard; Nandula Ekanayaka; Gregory M Cook
Journal:  BMC Microbiol       Date:  2009-12-10       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.